Two-in-One shot tested to shield seniors from common respiratory viruses
NCT ID NCT05903183
Summary
This study tested a single-shot vaccine designed to protect against two common respiratory viruses: RSV and human metapneumovirus (hMPV). It involved 264 healthy adults aged 60 to 85. The main goals were to check the vaccine's safety and see how well it triggered an immune response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AMR Lexington
Lexington, Kentucky, 40509, United States
-
AMR Phoenix
Tempe, Arizona, 85281, United States
-
ASR, LLC
Nampa, Idaho, 83587, United States
-
Cenexel RCA
Hollywood, Florida, 33024, United States
-
Clinical Research Atlanta
Stockbridge, Georgia, 30281, United States
-
Johnson City Clin-Trials (JCCT)
Lenexa, Kansas, 66219, United States
-
PanAmerican Clinical Research
Brownsville, Texas, 78520, United States
-
Rochester Clinical Research, Inc
Rochester, New York, 14609, United States
-
Velocity Clinical Research
Omaha, Nebraska, 68134, United States
-
Velocity Clinical Research-Boise
Meridian, Idaho, 83642, United States
Conditions
Explore the condition pages connected to this study.